Chugai Pharmaceutical Co., Ltd.
(Other OTC/NBB : CHGCY)

( )
CHGCY PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
PTLAPortola Pharmaceuticals, Inc. 0.56%17.956.5%$165.07m
HZNPHorizon Therapeutics Plc 4.06%50.736.5%$146.36m
CTLTCatalent, Inc. 0.81%77.522.3%$138.66m
MYOKMyoKardia, Inc. 2.14%102.291.8%$130.35m
BHCBausch Health Cos., Inc. -0.75%18.440.0%$119.26m
VRXValeant Pharmaceuticals International, Inc. -0.75%18.4414.1%$108.50m
UTHRUnited Therapeutics Corp. 2.57%117.9514.3%$75.18m
JAZZJazz Pharmaceuticals Plc 0.45%119.322.4%$60.64m
ICPTIntercept Pharmaceuticals, Inc. -0.66%72.2616.8%$59.67m
AMRNAmarin Corp. Plc 0.44%6.861.6%$57.99m
GWPHGW Pharmaceuticals Plc -2.16%122.756.2%$55.98m
ARGXargenx SE 3.60%219.300.0%$52.90m
AXSMAxsome Therapeutics, Inc. 0.60%76.981.9%$50.67m
PRGOPerrigo Co. Plc -0.42%54.806.8%$45.78m
ICLRICON plc 1.72%168.454.3%$44.44m

Company Profile

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety. The Research division focuses its efforts on creating innovative drugs by using its competitive strengths that include proprietary antibody technologies and cutting-edge research resources. The Development division provides cross-functional lifecycle management system to deliver innovative medicines to patients as quickly as possible. The Production division provides a world-class safety and quality management systems. The Marketing division conducts patient-oriented marketing activities to help solve issues related to healthcare. The Medical Affairs division works to properly deliver the value of medicines based on global compliance standards. The Drug Safety provides safety management system includes expert safety evaluation as well as timely gathering and reporting of safety information. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.